13F

Track13F

Track what the world's top investors are buying. SEC 13F filing data from institutional portfolio disclosures, updated quarterly.

HALO

Halozyme Therapeutics, Inc.• Healthcare

Institutional holders

949

Total 13F value

$44.5B

Sum of disclosed positions

New positions

0

This quarter

Sold positions

0

This quarter

Top holders

Institutions with disclosed positions in this stock

No holders available yet.

HALO — Who Owns Halozyme Therapeutics, Inc. | Track13F | Track13F